Skip to main content
Clinical Trials/NCT03148249
NCT03148249CompletedNot Applicable

A Randomized Control Trial of Patients With a Charles Bonnet Syndrome

Vienna Institute for Research in Ocular Surgery0 sites34 target enrollmentStarted: October 10, 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
34
Primary Endpoint
Quality of life score between the two groups

Study Overview

Brief Summary

Charles Bonnet Syndrome (CBS) is defined by the occurence of visual hallucinations (VH) in the absence of any mental disorder. Elderly patients with reduced visual acuity due to ophthalmic diseases are most affected. Conditions are often associated with the syndrome of age-related macular degeneration, cataract or glaucoma. Existing data on the syndrome's prevalence in Europe reveal diverse results. Aim of this study was to assess the prevalence of CBS in patients with low visual acuity and to evaluate, if an additional therapeutic interview with and treatment by a psychiatrist is beneficial.

Detailed Description

Patients with a visual acuity of 0.5 LogMAR or less in the better eye were screened for CBS. Instruments used were an interview asking for details of the hallucinations, a mental test and a scale concerning quality of life. Patients with CBS were randomized by minimization in two groups: in group 1, a patient-doctor interview by an ophthalmologist was performed and in group 2 an interview and if needed, a therapy by a psychiatrist. At the 3-months follow up, the psychological strain of patients was recorded again.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
55 Years to 105 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • written informed consent
  • visual acuity of 0.5 LogMAR or less at both eyes
  • 55 years or older
  • Patients with CBS:
  • have no mental pathologies such as dementia, psychosis or any other neurological diseases
  • have a normal cognitive state
  • are not able to control the VH
  • know that the VH are not real
  • are usually older
  • have significantly reduced visual acuity due to an bilateral eye pathology
  • VH associated with CBS:
  • disappear when the eyes are closed
  • are repetitive
  • are complex (eg. objects, geometrical patterns, faces, shapes, figures, scenes, animals or plants)

Exclusion Criteria

  • dopamine agonist medication
  • temporal lobe epilepsy
  • moderate to severe Alzheimer's dementia
  • present chronic alcohol-/drug abuse
  • bad cognitive state
  • There are no:
  • auditory or olfactory hallucinations
  • other abnormalities like delusions

Outcomes

Primary Outcomes

Quality of life score between the two groups

Time Frame: 3 months

Quality of life score between the study and control group

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Vienna Institute for Research in Ocular Surgery
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Prim. Prof. Dr. Oliver Findl, MBA

Univ. Prof. Dr., MBA

Vienna Institute for Research in Ocular Surgery

Similar Trials

A Trial of Patients With a Charles Bonnet... | Clinical Trial